<code id='78A81EB5B3'></code><style id='78A81EB5B3'></style>
    • <acronym id='78A81EB5B3'></acronym>
      <center id='78A81EB5B3'><center id='78A81EB5B3'><tfoot id='78A81EB5B3'></tfoot></center><abbr id='78A81EB5B3'><dir id='78A81EB5B3'><tfoot id='78A81EB5B3'></tfoot><noframes id='78A81EB5B3'>

    • <optgroup id='78A81EB5B3'><strike id='78A81EB5B3'><sup id='78A81EB5B3'></sup></strike><code id='78A81EB5B3'></code></optgroup>
        1. <b id='78A81EB5B3'><label id='78A81EB5B3'><select id='78A81EB5B3'><dt id='78A81EB5B3'><span id='78A81EB5B3'></span></dt></select></label></b><u id='78A81EB5B3'></u>
          <i id='78A81EB5B3'><strike id='78A81EB5B3'><tt id='78A81EB5B3'><pre id='78A81EB5B3'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:66719
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Sudafed saga points to U.S. issues with evaluating older drugs
          Sudafed saga points to U.S. issues with evaluating older drugs

          PATRICKT.FALLON/AFPviaGettyImagesYouwouldhavebeenforgivenforbeingsurprisedonSept.12whenapanelofadvis

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Covid vaccines: Private market messier than government rollout

          AhealthworkerdeliversashotofthePfizerCovid-19vaccineatacommunityhealthcenter.EraldoPeres/APThelatest